[1] Huys G, Cnockaert M, Vaneechoutte M, et al. Distribution of tetracycline resistance genes in genotypically related and unrelated multiresistant Acinetobacter baumannii strains from different european hospitals.Res Microbiol, 2005, 156:348-355.
[2] Loo W J, Kirtschig G, Wojnarowska F.Minocycline as a therapeutic option in bullous pemphigoid. Clin Exp Dermatol, 2001,26:376-379.
[3] 杨森,冯艺戎,张学军,等.四环素类药物抗氧自由基作用的研究.中国药理学通报,1999,15:472-473.
[4] Bernier C, Dreno B. Minocycline. Ann Dermatol Venereol, 2001, 128:627-637.
[5] Kalish RS, Koujak S. Minocycline inhibits antigen processing for presentation to human T cells:additive inhibition with chloroquine at therapeutic concentrations.Clin Immunol, 2004, 113:270-277.
[6] Yong VW, Wells J, Giuliani F, et al. The promise of minocycline in neurology. Lancet Neurol, 2004, 3:744-751.
[7] Wei X, Zhao L, Liu J, et al. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Neuroscience,2005, 131:513-521.
[8] Akamatsu H, Horio T, Hattori K. Increased hydrogen peroxide generation by neutrophils from patients with acne inflammation.Int J Dermatol, 2003, 42:366-369.
[9] Blum D, Chtarto A, Tenenbaum L, et al.Clinical potential of minocycline for neurodegenerative disorders. Neurobiol Dis,2004, 17:359-366.
[10] Romanowski B, Talbot H, Stadnyk M, et al.Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. Ann Intern Med, 1993, 119:16-22.
[11] 缪起龙,陈亚萍.美满霉素治疗男性尿道炎100例疗效观察.中国皮肤性病学杂志,2000,14:110-111.
[12] 周晓鸿.米诺环素治疗早期梅毒66例疗效分析.中华皮肤科杂志,2005,38:43.
[13] Zink MC,Uhrlaub J,DeWitt J,et al.Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA,2005, 293:2003-2011.
[14] Gaspar ZS, Walkden V, Wojnarowska F. Minocycline is a useful adjuvant therapy for pemphigus Australas J Dermatol, 1996, 37:93-95.
[15] Villahermosa LG, Fajardo TT Jr, Abalos RM.Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.m J Trop Med Hyg, 2004, 70:197-200.
[16] Arin MJ, Bate J, Krieg T, et al. Silicone granuloma of the face treated with minocycline. J Am Acad Dermatol, 2005, 52:53-56.
[17] Miralles J, Matarredona J, Ruiz JA, et al.Superficial granulomatous pyoderma. Cutis,2000, 66:217-219.
[18] Chang SN, Kim SC, Lee SH, et al. Minocycline treatment for confluent and reticulated papillomatosis. Cutis, 1996, 57:454-457.
[19] O'Dell JR, Blakely KW, Mallek JA, et al.Treatment of early seropositive rheumatoid arthritis:a two-year, double-blind comparison of minocycline and hydroxychloroquine.Arthritis Rheum, 2001, 44:2235-2241.
[20] Alster TS, Gupta SN. Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched alexandrite laser. Dermatol Surg,2004, 30:1201-1204.
[21] van Steensel MA. Why minocycline can cause systemic lupus-a hypothesis and suggestions for therapeutic interventions based on it. Med Hypotheses, 2004, 63:31-34.
[22] Antonov D, Kazandjieva J, Etugov D, et al.Drug-induced lupus erythematosus. Clin Dermatol, 2004, 22:157-166. |
